Our results revealed a number of associations for breast cancer lymph node metastasis, such as non-synonymous mutation burden, neoantigen burden, significantly different gene mutation rates, mutation hotspot distribution on TP53, tumor heterogeneity, neoantigen origin proteins and differentially expressed genes. This evidence concerns the gene TP53 and breast carcinoma.